What is OS Therapies's shares (diluted)?

OS Therapies (OSTX) reported shares (diluted) of 38.7M in Q1 2026.

How has OS Therapies's shares (diluted) changed year-over-year?

OS Therapies's shares (diluted) increased by 82.0% year-over-year, from 21.2M to 38.7M.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

OS Therapies OSTX Shares (Diluted)

Shares (Diluted) at other companies

ImmunomeIMNM

113.1M+42.5%

CTO

Citius Oncology, Inc.CTOR

100M+39.8%

Avalo TherapeuticsAVTX

20.1M+91.2%

Arcus BiosciencesRCUS

125.4M+27.4%

ImmunityBio, Inc.IBRX

1B+20.4%

WHW

Whitehawk Therapeutics, Inc. Common StockWHWK

69.2M+73.4%

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's shares (diluted)?: OS Therapies (OSTX) reported shares (diluted) of 38.7M in Q1 2026.
How has OS Therapies's shares (diluted) changed year-over-year?: OS Therapies's shares (diluted) increased by 82.0% year-over-year, from 21.2M to 38.7M.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.